TRAINING PROGRAM IN INVESTIGATIVE HEMATOLOGY

研究血液学培训计划

• 批准号: 6906461
• 负责人: LINDA M BOXER
• 金额: $ 4.95万
• 依托单位: STANFORD UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2001
• 资助国家: 美国
• 起止时间: 2001-08-27 至 2006-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6906461
• 关键词: TRAINING; PROGRAM; INVESTIGATIVE; HEMATOLOGY

EXCEED THE SPACE PROVIDED. The two major research directions for the Division of Hematology at Stanford are malignant hematology and vascular biology. This involvesboth basic and clinical research. The.program described herein will train postdoctoral fellows for a career in academic hematology. Candidates with MD or MD/PnD degrees who have completed training in Internal Medicine will be admitted to the three-year program. The first year of the program consists of an intensive training in clinical hematology,including benign and malignant hematology, stem cell and bone marrow transplantation, and transfusion medicine. In Year 2 and Year 3, the trainees will devote the majority of their time to research-based study. This will be done in a Basic-Scientist Pathway or a Clinical Investigator Pathway. The Basic Scientist Pathwayis primarily for trainees with substantialprior basic research experience, focusing on malignanthematology,vascularbiology and related basic research areas, The Clinical Investigator Pathway provides formal training in clinical research and incorporates the K30 Clinical Investigator Training program at Stanford under the direction of Dr. Mark Hlatky, leading to a Master's degree at the completion of formal training. In addition to the didactictraining, the Clinical Investigator Pathway fellow will also conduct hands-on clinical trials in the Division of Hematology. Fellow stipend support for the research training in Year 2 and Year 3 is requested in this grant application.More than three years of trainingis often required. Trainees are encouraged to apply for and obtain their own independentmentored research training support (K08 or K23) in Year 4. For each fellow, the research training will be supervised by a full-time faculty member in the Division of Hematology, or one of a numberof associate faculty members at Stanford University, representing disciplines relevant to hematology training. These include faculty in biochemistry, molecular pharmacology, microbiology, immunology, pathology, medical oncology, bone marrow transplantation, cardiology, pediatrics, epidemiology, outcome research and health policy. The progress of each fellow will be reviewed by the Program Director and the Training Program Steering Committee. At the conclusion of their training,trainees will be prepared for a career in academic hematology, as an independentinvestigator at the forefront of science and hematology. 'ERFORMANCE SITE(S) (organization, city, state) Stanford University School of Medicine, Palo Alto Veterans' Affairs Health Care System, Lucille Packard Children's Hospital KEY PERSONNEL ========================================Section End===========================================

超过提供的空间。斯坦福大学血液学分裂的两个主要研究方向是恶性血液学和血管生物学。这涉及基础研究和临床研究。本文所述的程序将培训博士后研究员从事学术血液学职业。完成内科培训的MD或MD/PND学位的候选人将被接受为期三年的计划。该计划的第一年包括在临床血液学方面进行的深入培训，包括良性和恶性血液学，干细胞和骨髓移植以及输血医学。在第二年和第三年，学员将大部分时间投入基于研究的研究。这将在基本科学家途径或临床研究者途径中完成。基础科学家Pathwayis主要针对具有丰富基础研究经验的学员，重点是恶性，血管生物学及相关基础研究领域，临床研究者途径在临床研究中提供了正式的培训，并在斯坦福大学的指导下纳入了K30临床研究者培训计划。马克·赫拉基（Mark Hlatky），在完成正规培训后获得硕士学位。除了教学方法外，临床研究者途径研究员还将在血液学分裂中进行动手临床试验。在本赠款申请中，要求对第2年和第3年进行研究培训的津贴支持。通常需要超过三年的培训。鼓励学员在第4年申请并获得自己的独立研究培训支持（K08或K23）。对于每个研究员，研究培训将由血液学系的全职教职员工进行监督，或斯坦福大学的副教育人数，代表与血液学培训有关的学科。其中包括生物化学，分子药理学，微生物学，免疫学，病理学，医学肿瘤学，骨髓移植，心脏病学，儿科，流行病学，结果研究和健康政策的教师。每个研究员的进度将由计划主任和培训计划指导委员会审查。在培训结束时，学员将为学术血液学职业做好准备，作为科学和血液学最前沿的独立评估者。 '超凡站点（S）（邮政局，州，州）斯坦福大学医学院，帕洛阿尔托退伍军人事务医疗保健系统，露西尔·帕卡德儿童医院关键人员================================================= ====================================================== ===================